Drug interactions
Dulaglutide + Empagliflozin-linagliptin
Severity: Moderate
Dulaglutide and Empagliflozin-linagliptin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Combining dulaglutide with empagliflozin and linagliptin gives additive glucose lowering. Linagliptin and dulaglutide both act on the incretin pathway, so adding a DPP-4 inhibitor to a GLP-1 agonist offers little extra benefit and adds cost and pill burden.
What this interaction means in plain words
Dulaglutide and Empagliflozin-linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dulaglutide belongs to Endocrine; Empagliflozin-linagliptin belongs to Endocrine.
Why it happens
Overlapping incretin-pathway activity plus additive antihyperglycemic effect of SGLT2 inhibition.
What to do
Avoid routine combination of a DPP-4 inhibitor with a GLP-1 agonist. Monitor glucose, volume status and gastrointestinal tolerability.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dulaglutide and Empagliflozin-linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Empagliflozin-linagliptin
Other interactions of Dulaglutide
Frequently asked questions
Can I take Dulaglutide with Empagliflozin-linagliptin?
MediHelp rates the interaction as moderate. Dulaglutide and Empagliflozin-linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Combining dulaglutide with empagliflozin and linagliptin gives additive glucose lowering. Linagliptin and dulaglutide both act on the incretin pathway, so adding a DPP-4 inhibitor to a GLP-1 agonist offers little extra benefit and adds cost and pill burden.
How serious is the interaction between Dulaglutide and Empagliflozin-linagliptin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine combination of a DPP-4 inhibitor with a GLP-1 agonist. Monitor glucose, volume status and gastrointestinal tolerability.
What other medicines interact with Empagliflozin-linagliptin?
MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Fosphenytoin, Rifampin, Rifapentine. The full list is on the Empagliflozin-linagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
